- Lobbying
- medicines
Lobbying Arrangements Results for 'Medicines'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details -Federal funding and regulation of innovative recombinant genetic technologies |
Editas Medicines, Inc.
|
FOLEY HOAG LLP | |||
Details gene - based medicines |
CRISPR Therapeutics AG
|
MMR, LLC | |||
Details HR 1778 |
The Medicines Company
|
Mr. John Lampmann | |||
Details Introduce Model Medicines and how the company is innovating at the intersection of data science, biology and drug development. |
Model Medicines
|
RESOLUTE-DC | |||
Details Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability; prescription drug supply ch... |
Venture Global on behalf of The Partnership for Safe Medicines
|
STACEY BARRACK D/B/A STACEY BARRACK | |||
Details Issues related to the Hatch-Waxman Act; proposed clarifying amendment to 3 U.S.C. 156. |
The Medicines Company
|
Mr. Peter Teeley | |||
Details intellectual property legislation |
PURDUE PHARMA L.P.
|
Constantine Cannon, LLP | |||
Details Patent extension/restoration |
The Medicines Company
Pharmaceuticals company that develpos acute care products for hospitals |
Fabiani & Company | |||
Details Intellectual property; issues related to Director of the US Patent & Trademark Office accepting late filings in certain cases of unintentional delay. |
The Medicines Company
|
PATTON BOGGS LLP | |||
Details S. 1906 Promising Pathway Act |
Praxis Precision Medicines
|
THE KPM GROUP DC LLC | |||
Details Potential legislation to protect public access to safe and genuine homeopathic medicines. |
Americans for Homeopathy Choice Action
|
in-house lobbying | |||
Details Patent Extension/Restoration |
Fabiani & Company on behalf of The Medicines Company
Government Relations Firm |
Heidepriem & Associates, LLC | |||
Details Addressing drug shortages and enhancing domestic production of critical medicines Issues related to biosimilars Promoting long-term sustainability for accessible medicines |
AMNEAL PHARMACEUTICALS
|
in-house lobbying | |||
Details Issues related to prescription drug importation, fentanyl scheduling, increased funding for law enforcement to combat fentanyl trafficking, combating pill presses, enhanced penalties for wholesale ... |
Venture Global on behalf of The Partnership for Safe Medicines
|
STEPHANIE A. BURGESS INC | |||
Details Opioid Legislation issues (no specific bill); Digital Medicines (general); Physician Fee Schedule, CPT codes Telehealth initiative proposed by FCC |
PROTEUS DIGITAL HEALTH, INC.
|
in-house lobbying | |||
Details Issues related to the Hatch-Waxman Act; Proposed clarifying amendment to 35 U.S.C. 156. |
DLA PIPER LLP (US) (for The Medicines Company)
|
TCK International, LLC | |||
Details Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues |
Alliance to Prevent the Abuse of Medicines
|
RUBICON ADVISORS, LLC | |||
Details Intellectual property, issues of filing deadlines under the Hatch-Waxman Act for patent term restoration, H.R. 1249, America Invents Act |
The Medicines Company
|
KEN CUNNINGHAM GROUP, LLC | |||
Details Hatch-Waxman deadlines. |
THE MEDICINES COMPANY
|
Wilmer Cutler Pickering Hale and Dorr, LLP | |||
Details H.R. 6344 - Responsive Government Act of 2008 - patent issue. |
WILMER, CUTLER, PICKERING, HALE & DORR (ON BEHALF OF THE MEDICINES COMPANY)
|
VERN CLARK & ASSOCIATES, INC. | |||
Details Expanded Access |
myTomorrows
|
KING & SPALDING LLP | |||
Details Monitoring of Appropriations process and developments including Patent and Trademark Office |
The Medicines Company
|
Cornerstone Government Affairs, LLC | |||
Details Issues relating to filing deadline under the Hatch-Waxman Act for patent term restorations. |
The Medicines Company
|
Cove Strategies | |||
Details Issues related to Hatch-Waxman Act and to U.S. Patent and Trademark Office Director accepting late filings in certain cases of unintentional delay |
THE MEDICINES COMPANY
|
KING & SPALDING LLP | |||
Details Drug pricing, gene therapy, and rare disease funding generally; Advancing Access to Precision Medicine; Newborn Screening Saves Lives Reauthorization Act; Genome Editing Threat Assessment Act; Medi... |
Homology Medicines
|
Burrell International Group LLC | |||
Details patent issue; H.R.5486, Small Business Jobs Tax Relief Act of 2010 |
The Medicines Company
manufacture and marketing of pharmaceutical drugs |
Gephardt Group Government Affairs | |||
Details Proposals to require Registries/Registrars to Lock & Suspend Domain Names Used to Facilitate Illegal Online Drug Sales; Proposals to require online Search/Social/Marketplace Platforms to Report Ill... |
Venture Global on behalf of The Partnership for Safe Medicines
public health advocacy for safe prescription medicines. |
NICOLE SEMENZA LLC | |||
Details Antibiotics development as it relates to various legislative proposals and agency rulemaking activities |
The Medicines Company
Pharmaceutical manufacturer |
SIDLEY AUSTIN LLP | |||
Details Provide strategic counsel related to patent reform provisions, general appropriations, health care and other legislation |
The Medicines Company
|
Barbour Griffith & Rogers, LLC d/b/a BGR Government Affairs | |||
Details HR 1548-Pathway for BioSimiliars Act; all provisions HR 1427-Promoting Innovation & Access to Life Saving Medicines Act; all provisions |
Amgen
|
Mattoon & Associates, LLC | |||
Details COVID -19 Stimulus Package (domestic manufacturing) |
Summit Therapeutics plc
Biopharmaceutical company; develops medicines to treat infectious diseases |
THE KPM GROUP DC LLC | |||
Details Issues related to Hatch-Waxman Act and issues related to the Director of the U.S. Patent & Trademark Office accepting late filings in certain cases of unintentional delay |
Wilmer, Cutler, Pickering, Hale & Dorr (on behalf of The Medicines Company)
|
KEN CUNNINGHAM GROUP, LLC | |||
Details Issues related to travel and health Access to medicines aboard commercial airlines Availability of medicines on commercial airplanes |
Coalition for Lifesaving Epinephrine Access and Responsibility
|
Mr. Robert Houton | |||
Details Generic competition, CREATES Act, USMCA, on-shoring pharmaceutical manufacturing |
Association for Accessible Medicines
|
Quadripoint Strategies LLC | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
The Medicines Company
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Increase federal funding for malaria research at the Department of Defense and the Department of Health and Human Services. |
MMV Medicines for Malaria Venture
|
Cornerstone Government Affairs, Inc. | |||
Details Protecting patients and consumers from counterfeit, substandard and otherwise unsafe medications |
The Safdar Group (on behalf of the Partnership for Safe Medicines)
|
Jones Public Affairs, Inc. | |||
Details House and Senate legislation on biologic medicines. |
Teva Pharmaceuticals USA
|
KIRKLAND & ELLIS LLP | |||
Details Domestic manufacturing of essential generic medicines; supply chain disruptions and shortages of foreign manufactured medicines Domestic manufacturing of essential generic medicines Funding for dom... |
Phlow Corporation
|
WINNING STRATEGIES WASHINGTON | |||
Details Issues related to importation of medicines for personal use. |
Canadian International Pharmacy Association
|
LINCOLN PARK GROUP L.L.C. | |||
Details Track and trace technologies for safe medicines |
NOVARTIS
|
CROWELL & MORING INTERNATIONAL, LTD. | |||
Details Advocacy related to value-based payments for regenerative medicines |
Audentes Therapeutics
|
KING & SPALDING LLP | |||
Details PREVAIL Act, S.2220. Opposition to legislative efforts to weaken the Patent Trial & Appeal Board at the USPTO. |
Association of Accessible Medicines
Trade association working to make generic and biosimilar medicines are more accessible. |
Endgame Strategies, LLC | |||
Details Antibiotic development |
Theravance
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Provision relating to proposed Amendments to title 35, United States Code. |
THE MEDICINES COMPANY
|
Gibbons P.C. | |||
Details Regulation of over-the-counter asthma-cough medicines. |
CB Distributors, Inc.
|
Duane Morris Government Affairs | |||
Details Issues related to the Hatch-Waxman Act; H.R. 1778, to amend Title 35 of the U.S. Code with respect to U.S. Patent and Trademark Office procedures. |
The Medicines Company
Pharmaceutical manufacturer |
Ms. Jennifer Dunn | |||
Details H.R. 34, the 21st Century Cures Act H.R. 512, the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act S. 145, the Promise for Antibiotics and Therapeutics for Health Ac... |
The Medicines Company
|
BAKER & HOSTETLER LLP | |||
Details Implementation of the Inflation Reduction Act of 2022; Help Copays Act (HR 830 / S. 1375); Orphan Cures Act (HR 5539); Issues related to rare disease research incentives; National Plan to End P... |
ACADIA PHARMACEUTICALS
|
in-house lobbying | |||
Details Coding, coverage and reimbursement of pharmaceuticals |
The Medicines Company
Global Pharmaceutical company |
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ |